RENVELA® TABLETS
Film-coated tablets
registration number
45/32.16/0305
What RENVELA® TABLETS contains
800 mg of sevelamer carbonate on an anhydrous basis.
other ingredients
Tablet core:
Microcrystalline cellulose
Sodium chloride
Zinc stearate
Film coating:
Opadry Clear containing:
Diacetylated monoglycerides
Hypromellose (E464).
Therapeutic classification
V03A E02.